Clinical Trials Browser

Completed × Osteosarcoma × apatinib × Clear all

NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Phase NA Completed

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Phase 2/3 Completed

Neoplasm Metastasis, Osteosarcoma